SCHEMBL25830894

SCHEMBL25830894

N#Cc1ccc(Cl)cc1-c1cc[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PSMB8 P28062 2/20 0.41
VCAM1 P19320 1/20 0.38
PRMT5 O14744 2/20 0.37
WDR77 Q9BQA1 2/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CYP2A6 P11509 1/20 0.35
IDO1 P14902 1/20 0.35
USP8 P40818 2/20 0.35
USP7 Q93009 2/20 0.35
USP47 Q96K76 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
EIF4E P06730 1/20 0.34
DYRK1A Q13627 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL25378498 0.98 KDM4E (0.43) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL28242325 0.81 PRMT5 (0.36) KDM4EMAPTTDP1PRMT5WDR77
SCHEMBL11624239 0.78 IDO1 (0.56) MAPTIDO1ALDH1A1MEN1HPGD
SCHEMBL25258024 0.76 KDM4E (0.40) KDM4EMAPTTDP1PSMB8VCAM1
SCHEMBL30926124 0.76 ESR2 (0.42) USP8USP7L3MBTL1
SCHEMBL3401714 0.76 ESR2 (0.42) USP8USP7L3MBTL1
SCHEMBL25378423 0.76 CYP11B1 (0.47) KDM4EMAPTPRMT5WDR77ALDH1A1
SCHEMBL26192949 0.76 AR (0.46) KDM4EMAPTPRMT5WDR77MAOA
SCHEMBL1806235 0.75 AR (0.41) KDM4EMAPTTDP1ARL3MBTL1
Hydrochloric Acid SCHEMBL25255925 0.75 CYP11B1 (0.46) KDM4EMAPTPRMT5WDR77ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
WO-2023122780-A9 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
WO-2023122780-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 1163/4885MAPT 2994/4885TDP1 1073/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 KDM4E 1163/4885MAPT 2994/4885TDP1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.